Aktienanalyse zu Medline Inc (MDLN)MDLNMedline Inc

Medline Inc. is a provider of medical-surgical products and supply chain solutions serving all points of care. The Company delivers mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities. It operates through two segments: Medline Brand and Supply Chain Solutions. These segments offer approximately 335,000 medical-surgical products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. Its Medline Brand products are organized into three product categories: Front Line Care, Surgical Solutions, and Laboratory and Diagnostics. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands and also provides tailored logistics and supply chain optimization services to domestic and international consumers. It operates in the Healthcare sector.

Medline Inc. is a good buy right now due to its recent strong earnings performance, with a reported EPS of $0.50, beating expectations by $0.18, and a revenue of $7.7 billion for Q2, reflecting an 11.6% year-over-year growth. However, the risk lies in the lowered EBITDA outlook, now projected between $3.3 billion to $3.4 billion, which is below market expectations.